No takes yet. Share an insight, caveat, or question.
This special report outlines the IFCC Committee's concerns regarding the 2020 ESC guidelines on the use of high-sensitivity cardiac troponin in NSTE-ACS.
Apple et al. (2020) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: